- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Zibotentan/Dapagliflozin - Formulation 2 (Treatment C)
Total 89 results
-
AstraZenecaCompletedChronic Kidney DiseaseUnited States
-
AstraZenecaRecruitingLiver CirrhosisDenmark, Spain, Germany, United States, France, Australia, China, Belgium, Netherlands, Switzerland, Austria, United Kingdom, Taiwan, Canada, Czechia
-
AstraZenecaRecruitingLiver CirrhosisItaly, Japan, Germany, Belgium, Poland, Australia, United States, United Kingdom, Czechia, Slovakia
-
University Medical Center GroningenAstraZenecaEnrolling by invitationChronic Kidney DiseasesNetherlands, Canada, United States, Denmark, United Kingdom
-
Boehringer IngelheimCompleted
-
PfizerCompleted
-
AstraZenecaRecruitingChronic Kidney Disease With High ProteinuriaItaly, United States, Poland, Germany, Argentina, Denmark, Norway, Spain, Sweden, Bulgaria, France, China, Taiwan, Thailand, Vietnam, Brazil, Japan, Malaysia, Mexico, Philippines, Israel, United Kingdom, South Africa, Austria, Korea, Republic... and more
-
Janssen Research & Development, LLCCompleted
-
PfizerActive, not recruitingClostridoides Difficile Associated DiseaseUnited States
-
Chong Kun Dang PharmaceuticalCompletedHypertension | DyslipidemiasKorea, Republic of
-
Boehringer IngelheimCompleted
-
AstraZenecaParexelCompletedCoronary Artery Disease (CAD)United Kingdom
-
Sucampo Pharma Americas, LLCTakedaCompletedHealthy VolunteersUnited States
-
Medicines for Malaria VentureQuotient ClinicalCompleted
-
Boehringer IngelheimActive, not recruiting
-
AstraZenecaCompletedChronic Kidney DiseaseUnited States, Italy, Spain, Brazil, Malaysia, Australia, South Africa, Hungary, Georgia, Japan, Bulgaria, Poland, Ukraine, Denmark, Argentina, Slovakia, Canada, Croatia, Netherlands
-
PfizerArvinas Estrogen Receptor, Inc.Recruiting
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
AstraZenecaAcerta Pharma, LLCCompletedBioavailability | B-cell Lymphoid CancerUnited States
-
AstraZenecaCompletedUncontrolled and Persistent AsthmaUnited Kingdom
-
Boehringer IngelheimCompleted
-
PfizerCompletedRheumatoid Arthritis | Healthy VolunteersUnited States
-
Janssen Research & Development, LLCCompleted
-
Boehringer IngelheimCompleted
-
Janssen Research & Development, LLCCompleted
-
AJU Pharm Co., Ltd.CompletedT2DM (Type 2 Diabetes Mellitus)Korea, Republic of
-
Janssen Research & Development, LLCCompleted
-
AllerganCompletedAlopecia | BaldnessUnited States, Germany
-
Janssen Research & Development, LLCCompleted
-
Children's Hospital of Fudan UniversityWithdrawnChronic Kidney Diseases | ProteinuriaChina
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
AstraZenecaTerminatedType 2 Diabetes MellitusThailand, Vietnam
-
Fondazione SchenaUniversity of BariRecruitingGlomerulonephritis | Immunoglobulin A NephropathyItaly
-
Osaka UniversityUnknownDiabetes Mellitus, Type 2Japan
-
AstraZenecaParexelCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Janssen-Cilag International NVCompleted
-
Cerevel Therapeutics, LLCRecruitingHealthy ParticipantsUnited States
-
Tanta UniversityNot yet recruiting
-
University of OxfordBiopharma (Orofino Pharmaceuticals Group)Not yet recruiting
-
National and Kapodistrian University of AthensHippocration General Hospital; Alexandra Hospital, Athens, GreeceCompletedLiver Steatosis | Non-Alcoholic Fatty Liver DiseaseGreece
-
Hoffmann-La RocheCompletedHealthy VolunteersUnited States
-
University of MichiganUniversity of Colorado, Denver; Renal Pre-Competitive Consortium (RPC3)Recruiting
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Omar YounisAin Shams UniversityCompleted
-
GlaxoSmithKlineCompleted
-
PfizerCompletedBiological AvailabilityUnited States
-
Nanjing First Hospital, Nanjing Medical UniversityActive, not recruitingType 2 Diabetes MellitusChina
-
Boehringer IngelheimCompleted